Northern Trust’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-27,778
| Closed | -$73.9K | – | 4523 |
|
|
2024
Q1 | $73.9K | Hold |
27,778
| – | – | ﹤0.01% | 4153 |
|
|
2023
Q4 | $65.8K | Hold |
27,778
| – | – | ﹤0.01% | 4185 |
|
|
2023
Q3 | $38.9K | Sell |
27,778
-231
| -0.8% | -$323 | ﹤0.01% | 4226 |
|
|
2023
Q2 | $84.9K | Sell |
28,009
-183,846
| -87% | -$557K | ﹤0.01% | 4081 |
|
|
2023
Q1 | $1.32M | Sell |
211,855
-2,961
| -1% | -$18.5K | ﹤0.01% | 3116 |
|
|
2022
Q4 | $1.31M | Sell |
214,816
-5,808
| -3% | -$35.4K | ﹤0.01% | 3171 |
|
|
2022
Q3 | $2.64M | Sell |
220,624
-4,982
| -2% | -$59.5K | ﹤0.01% | 2863 |
|
|
2022
Q2 | $2.85M | Buy |
225,606
+17,769
| +9% | +$224K | ﹤0.01% | 2858 |
|
|
2022
Q1 | $2.34M | Sell |
207,837
-5,700
| -3% | -$64.2K | ﹤0.01% | 3019 |
|
|
2021
Q4 | $3.78M | Buy |
213,537
+2,184
| +1% | +$38.7K | ﹤0.01% | 2865 |
|
|
2021
Q3 | $4.87M | Buy |
211,353
+75,840
| +56% | +$1.75M | ﹤0.01% | 2749 |
|
|
2021
Q2 | $3.16M | Sell |
135,513
-10,095
| -7% | -$235K | ﹤0.01% | 3122 |
|
|
2021
Q1 | $4.54M | Buy |
+145,608
| New | +$4.54M | ﹤0.01% | 2817 |
|